ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/12/02 | 4,961 | 4,999 | 4,886 | 4,890 | +69 | +1.4% | 368,100 |
2024/11/29 | 4,855 | 4,869 | 4,821 | 4,821 | -24 | -0.5% | 128,500 |
2024/11/28 | 4,809 | 4,867 | 4,809 | 4,845 | +48 | +1% | 178,500 |
2024/11/27 | 4,822 | 4,835 | 4,751 | 4,797 | -39 | -0.8% | 218,700 |
2024/11/26 | 4,770 | 4,870 | 4,770 | 4,836 | +85 | +1.8% | 222,000 |
2024/11/25 | 4,878 | 4,888 | 4,751 | 4,751 | -107 | -2.2% | 242,800 |
2024/11/22 | 4,804 | 4,861 | 4,774 | 4,858 | +35 | +0.7% | 158,500 |
2024/11/21 | 4,920 | 4,944 | 4,815 | 4,823 | -64 | -1.3% | 201,000 |
2024/11/20 | 4,942 | 4,950 | 4,850 | 4,887 | -34 | -0.7% | 158,500 |
2024/11/19 | 4,752 | 4,936 | 4,708 | 4,921 | +144 | +3% | 288,500 |
2024/11/18 | 4,760 | 4,809 | 4,747 | 4,777 | -23 | -0.5% | 234,900 |
2024/11/15 | 4,884 | 4,915 | 4,792 | 4,800 | -84 | -1.7% | 329,100 |
2024/11/14 | 4,862 | 4,912 | 4,833 | 4,884 | -25 | -0.5% | 189,600 |
2024/11/13 | 4,906 | 4,946 | 4,853 | 4,909 | -45 | -0.9% | 215,300 |
2024/11/12 | 5,000 | 5,049 | 4,898 | 4,954 | +89 | +1.8% | 475,600 |
2024/11/11 | 4,862 | 4,933 | 4,804 | 4,865 | +73 | +1.5% | 312,500 |
2024/11/08 | 4,890 | 4,948 | 4,729 | 4,792 | -168 | -3.4% | 702,100 |
2024/11/07 | 4,929 | 4,995 | 4,811 | 4,960 | +40 | +0.8% | 777,200 |
2024/11/06 | 4,862 | 4,968 | 4,825 | 4,920 | +60 | +1.2% | 248,700 |
2024/11/05 | 4,670 | 4,878 | 4,620 | 4,860 | -20 | -0.4% | 448,400 |
2024/11/01 | 4,932 | 5,000 | 4,870 | 4,880 | -127 | -2.5% | 234,300 |
2024/10/31 | 5,092 | 5,097 | 4,971 | 5,007 | -63 | -1.2% | 322,300 |
2024/10/30 | 5,049 | 5,116 | 5,034 | 5,070 | +47 | +0.9% | 900,600 |
2024/10/29 | 4,972 | 5,037 | 4,910 | 5,023 | +73 | +1.5% | 333,000 |
2024/10/28 | 4,918 | 4,972 | 4,880 | 4,950 | +48 | +1% | 235,800 |
2024/10/25 | 4,887 | 4,910 | 4,834 | 4,902 | -21 | -0.4% | 318,100 |
2024/10/24 | 4,859 | 4,934 | 4,833 | 4,923 | +27 | +0.6% | 232,500 |
2024/10/23 | 4,911 | 4,959 | 4,889 | 4,896 | -16 | -0.3% | 158,600 |
2024/10/22 | 4,896 | 4,934 | 4,890 | 4,912 | -10 | -0.2% | 277,800 |
2024/10/21 | 4,893 | 4,937 | 4,858 | 4,922 | +35 | +0.7% | 304,200 |
2024/10/18 | 4,905 | 4,930 | 4,882 | 4,887 | +6 | +0.1% | 229,000 |
2024/10/17 | 4,955 | 4,955 | 4,852 | 4,881 | -65 | -1.3% | 345,100 |
2024/10/16 | 4,944 | 5,050 | 4,940 | 4,946 | +33 | +0.7% | 321,900 |
2024/10/15 | 4,933 | 4,945 | 4,870 | 4,913 | -12 | -0.2% | 357,400 |
2024/10/11 | 4,981 | 4,990 | 4,906 | 4,925 | -67 | -1.3% | 348,100 |
2024/10/10 | 5,000 | 5,019 | 4,926 | 4,992 | +28 | +0.6% | 357,400 |
2024/10/09 | 5,042 | 5,057 | 4,925 | 4,964 | +20 | +0.4% | 492,600 |
2024/10/08 | 5,030 | 5,138 | 4,935 | 4,944 | -65 | -1.3% | 717,200 |
2024/10/07 | 4,900 | 5,016 | 4,877 | 5,009 | +123 | +2.5% | 638,100 |
2024/10/04 | 4,746 | 4,890 | 4,730 | 4,886 | +140 | +2.9% | 620,400 |
2024/10/03 | 4,874 | 4,920 | 4,708 | 4,746 | -58 | -1.2% | 1,226,600 |
2024/10/02 | 4,700 | 4,871 | 4,691 | 4,804 | +114 | +2.4% | 815,000 |
2024/10/01 | 4,565 | 4,690 | 4,541 | 4,690 | +178 | +3.9% | 763,000 |
2024/09/30 | 4,449 | 4,561 | 4,431 | 4,512 | +41 | +0.9% | 754,400 |
2024/09/27 | 4,425 | 4,517 | 4,420 | 4,471 | -50 | -1.1% | 515,900 |
2024/09/26 | 4,400 | 4,530 | 4,381 | 4,521 | +180 | +4.1% | 869,800 |
2024/09/25 | 4,230 | 4,375 | 4,220 | 4,341 | +100 | +2.4% | 567,500 |
2024/09/24 | 4,125 | 4,254 | 4,105 | 4,241 | +270 | +6.8% | 759,400 |
2024/09/20 | 3,977 | 3,989 | 3,950 | 3,971 | +21 | +0.5% | 331,100 |
2024/09/19 | 3,950 | 3,975 | 3,941 | 3,950 | +54 | +1.4% | 142,600 |
101~
150
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム